Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.4.10 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.4.10 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.10 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.4.10 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.4.10 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.4.10 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.4.10 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.10 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.47EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.47ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.47ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.47EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.47EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.282EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.282EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.282ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.282ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.282EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.282EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.282ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.282ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.131EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.131EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.131ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.131ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.131EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.131EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.131ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.131ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.274EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.274EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.274ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.274ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.274EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.274EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.274ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.274ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used